MENU
+Compare
EW
Stock ticker: NYSE
AS OF
Dec 17, 04:59 PM (EDT)
Price
$74.11
Change
+$0.20 (+0.27%)
Capitalization
57.52B

EW Edwards Lifesciences Corp Forecast, Technical & Fundamental Analysis

a manufacturer of products to treat late-stage cardiovascular disease

EW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for EW with price predictions
Dec 17, 2024

EW's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for EW turned positive on November 18, 2024. Looking at past instances where EW's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 15, 2024. You may want to consider a long position or call options on EW as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

EW moved above its 50-day moving average on November 15, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EW crossed bullishly above the 50-day moving average on November 21, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EW advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 260 cases where EW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for EW moved out of overbought territory on December 05, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EW broke above its upper Bollinger Band on December 04, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.532) is normal, around the industry mean (23.300). P/E Ratio (40.978) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (5.416) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (9.569) is also within normal values, averaging (43.338).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
EW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EW is expected to report earnings to fall 17.75% to 55 cents per share on January 30

Edwards Lifesciences Corp EW Stock Earnings Reports
Q4'24
Est.
$0.55
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.02
Q4'23
Est.
$0.64
The last earnings report on October 24 showed earnings per share of 67 cents, beating the estimate of 66 cents. With 7.07M shares outstanding, the current market capitalization sits at 57.52B.
A.I. Advisor
published General Information

General Information

a manufacturer of products to treat late-stage cardiovascular disease

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Edwards Way
Phone
+1 949 250-2500
Employees
19800
Web
https://www.edwards.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IBIO2.420.07
+2.98%
iBio
STT98.70-2.08
-2.06%
State Street Corp
YSG4.65-0.12
-2.52%
Yatsen Holding Limited
MHO150.73-3.96
-2.56%
M/I Homes
PACB1.97-0.08
-3.90%
Pacific Biosciences of California

EW and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EW has been loosely correlated with RVTY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if EW jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EW
1D Price
Change %
EW100%
+0.28%
RVTY - EW
53%
Loosely correlated
-0.36%
BSX - EW
43%
Loosely correlated
-0.03%
SYK - EW
42%
Loosely correlated
-0.51%
WST - EW
42%
Loosely correlated
+1.12%
ALGN - EW
40%
Loosely correlated
-0.56%
More